These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 23568993)

  • 1. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic Inflammatory Myopathy and Anti-aminoacyl-tRNA Synthetase Antibody].
    Maeda MH
    Brain Nerve; 2018 Apr; 70(4):439-448. PubMed ID: 29632291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
    J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
    Mahler M; Miller FW; Fritzler MJ
    Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
    Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
    Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of myositis-specific autoantibodies.
    Nakashima R
    Immunol Med; 2018 Sep; 41(3):103-112. PubMed ID: 30938275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in polymyositis and dermatomyositis.
    Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
    Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisynthetase syndrome].
    Gran JT
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
    Phuong TNT; Ngoc LNT; Rönnelid J; Padyukov L; Lundberg IE
    Int J Rheum Dis; 2021 May; 24(5):663-670. PubMed ID: 33788398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.